Aldeyra Therapeutics (NasdaqCM:ALDX) FY Conference September 08, 2025 11:30 AM ET Company ParticipantsTodd Brady - CEO, President & DirectorConference Call ParticipantsMatthew Caufield - VP - Senior Healthcare AnalystMatthew CaufieldHey, welcome everyone to the H.C. Wainwright & Co. Global Investment Conference. My name is Matthew Caulfield, Senior Biotech Analyst here at H.C. Wainwright & Co., and we're pleased to be joined by Dr. Todd C. Brady, CEO of Aldeyra Therapeutics. Todd, great to see you as always ...